IL-4 decreases Fc-gamma-R membrane expression and Fc-gamma-R-mediated cytotoxic activity of human monocytes by Velde, A.A. te et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/27194
 
 
 
Please be advised that this information was generated on 2018-07-07 and may be subject to
change.
0 0 2 2 -1 7 6 7 /9 0 /1 4 4 8 -3 0 4 6 8 0 2 .OOyO 
T he J o u r n a l  o f  I m m u n o l o g y
Copyright© 1990 by The American Association of Immunologists
Vol. 144, 3 0 4 6 -3 0 5 1 . No. 8, April 15. 1990
Printed in U.S.A.
IL-4 DECREASES FctR MEMBRANE EXPRESSION AND Fc^R-MEDIATED 
CYTOTOXIC ACTIVITY OF HUMAN MONOCYTES1
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Monocytes can express three classes of FcR  for 
IgG: FcyR I, FcyR II, and FcyR III (CD64, CD32, and 
CD16, respectively) of which the FC7 R III is ex­
pressed after prolonged culture* FC7 R  expression is 
regulated by IFN-7 . Because IFN - 7  and IL-4 have 
antagonistic effects on the expression of the FcR  for 
Ig E  on human monocytes, we studied the effect of 
IL-4 on FC7 R expression and function. We show that 
IL-4 down-regulates FC7 RI, FC7 R II, and FC7 R III 
expression of cultured monocytes and inhibits 
IFN - 7  enhanced FC7 R I expression. Exposure of 
m onocytes to IL-4 for 40 h resulted in a dose-de­
pendent decrease of the expression of a ll three FcyR 
th a t persisted throughout the whole culture period 
(7 days). Anti-IL-4 antibodies com pletely reversed 
the IL-4 effect. In  addition the im paired FC7 R expres­
sion correlated d irectly w ith reduced Fc 7 R-me- 
diated function because monocytes cultured in the 
presence of IL-4 have a reduced capacity to lyse 
hum an E opsonized w ith human IgG anti-D or mouse 
antiglycophorin A  antibodies. These observations, 
together w ith the previous finding that IL-4 induces 
FctR IIb  expression on monocytes, indicate that IL-4 
and IFN - 7  may control the Fc 7 R-mediated immune 
response by d ifferentially regulating FcyR  expres­
sion.
Soluble  m ediators in fluencing  m onocyte activ ity  in ­
c lu d e  bacteria-derived  com ponents, and  a  n u m b e r  of dif­
f e r e n t  lym phokines an d  m onokines (1). IFN-7 is one of 
th e  com m on m onocyte ac tiva to rs  th a t  induces the 
ex p ress io n  of c lass II MHC Ag a n d  of FcR for IgG on 
h u m a n  m onocytes (2-4). R ecently  o ther fac to rs  have 
b e e n  described th a t  possess m onocyte-activating  activity, 
s u c h  a s  granulocyte-m acrophage-C SF (5) a n d  IL-4 (6). 
M onocytes exposed to IL-4 show  en h an ced  expression  of 
MHC class II Ag, CD 11 b/CD 18, a n d  CD 11 c/CD 18 (6), and 
d isp la y  a  reduced capacity  to secre te  IL-1 an d  TNF-tt (7)3.
IL-4 also induces th e  expression  of th e  low affin ity
Received for publication October 16, 1989.
Accepted for publication January 9, 1990.
The costs of publication of this article were defrayed in part by the 
payment of page charges. This article must therefore be hereby marked 
advertisement  in accordance with 18 U.S.C. Section 1734 solely to indi­
cate this fact.
1 This work is supported by Grant NKI 86-1 from the Dutch Cancer 
Society.
2 Address correspondence and reprint requests to A, A. te Velde, Divi­
sion of Immunology, The Netherlands Cancer Institute, Plesmanlaan 121, 
1066 CX Amsterdam, The Netherlands,
3 Te Velde, A. A., R. J, F. Huijbens, C. Heije, J. E. de Vries, and C, G.
Figdor. 1989. Interleukin-4 inhibits secretion of interleukin-10, tumor
necrosis factor <x and interleukin-6 by human monocytes. Submitted for
publication .
FceRII/CD23 (8).4 IL-4 specifically induces expression of 
th e  FceRIIb, because  anti-IL-4 antibodies block lL-4-in- 
duced expression an d  no other lym phokine h as  a  sim ilar 
effect. This prom pted  u s  to investigate the  effect of IL-4 
on the  expression an d  function of o ther monocyte FcR. 
Monocytes can  express three classes of FcR for IgG: 
FcrRI, FcyRII, an d  FcyRIII (CD64, CD32, and  CD16, re ­
spectively) (9), of w hich  th e  FcyRIII is only expressed w ith 
length of tim e in  cu ltu re  (10, 11). These FcyR  a re  im por­
ta n t  m ediators in  th e  clearance of im m une complexes, 
phagocytosis* an d  ADCC activity (12). The resu lts  of th is  
study  show  th a t IL-4 reduces the  expression of all th ree  
FcR for IgG on h u m a n  monocytes th a t  correlate with a 
reduced capacity  to lyse antibody opsonized E.
MATERIALS AND METHODS
Isolation and culture of human monocytes. Human peripheral 
blood monocytes were isolated from 500 ml blood of normal human 
donors, as described previously (13, 14). Mononuclear cells were 
isolated by density centrifugation in a blood component separator, 
followed by fractionation into lymphocytes and monocytes by cen­
trifugal élutriation. The monocyte preparation was over 95% pure, 
as judged by nonspecific esterase staining and contained more than 
98% viable cells. Monocytes were cultured in Yssel’s medium (15) 
containing HSA5 and supplemented with 1% autologous or pooled 
heat inactivated human serum. This culture medium was endotoxin 
free as determined by the Limulus amebocyte lysate assay (less than
0.2 ng/ml of endotoxin). The monocytes were incubated at a concen­
tration of 4 X 106 cells per ml in Teflon bags (Jansen MNL, St. 
Niklaas, Belgium).
After culture for 40 h the monocytes were harvested from the 
Teflon bags. The cells were washed, resuspended, and kept on ice 
until use. The viability by Trypan blue exclusion exceeded 90%. 
There was no difference in the number of cells that were recovered 
after culture with IL-4 and/or IFN-7 compared with control cultures 
(over 80%).
rIL-4, rIFN-y, and antt-lL-4 antiserum. Recombinant human 
IL-4 was obtained as a purified protein from super n at ants of L cells 
transfected with the cDNA clone encoding IL-4 (sp. act. 107 U/ml), 
kindly provided by Dr. S. Nagabhushan (Schering-Plough Corpora­
tion, Bloomfield, NY), One U of IL-4 was defined as the concentration 
of IL-4 resulting in half maximal proliferation of PHA-activated T 
lymphoblasts (16), Human rIFN-7 (sp. act. 107 U/ml) was kindly 
provided by Drs. P. Trotta and S. Nagabhushan (Schering-Plough 
Corporation), The polyclonal rabbit anti-IL-4 antiserum that blocks 
the biologic activity of IL-4 as has been described previously (16).
Detection of surface membrane determinants. FC7 RI, Fc-yRII, 
and FC7RIII expression was measured on monocytes cultured in 
medium only or in the presence of IL-4 and/or IFN-7 . The anti-FcR 
antibodies used were 32.2 (IgG2a) and IV.3 (IgG2b) directed against 
FC7 RI and FC7RII, respectively» These mAb were both purchased 
from Medarex Inc. (West Lebanon, NH). The anti-Fc7RIII used was 
the CLB/FcR gran 1 (IgG2a) kindly provided by T. W. J. Huizinga 
(Central Laboratory of the Netherlands Red Cross Blood Transfusion
4 Te Velde, A. A., F. Rousset, F. Peronne, J. E. de Vries, and C. G. 
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Figure 1. IL-4 inhibits the expression of FC7RI, FC7RII, and FC7 RIII. It enhances the expression of class II MHC Ag HLA-DR/DP and It Induces the 
expression of FceRIIb on human monocytes. The cells were cultured for 40 h with and without 100 U/ml of IL-4. The various Ag were detected after 
subsequent staining with specific mAb and GAM F(ab)2 FITC. The fluorescence Intensity (arbitrary units) of 5000 cells was determined with a 
FACScan. One representative experiment of 10 is shown.
Service, Amsterdam, the Netherlands) (18). MHC class II Ag were 
detected using Q 5/13 (IgG2a) that detects a determinant common to 
HLA-DR and HLA-DP molecules (19). Q 5/13 was a gift from Dr. S. 
Ferrone, Medical College, Valhalla, NY. FceRIIb was determined by 
the binding of the Fc6RII/CD23-specific mAb 25 (IgGl) (20). Control 
antibodies of IgG2a isotype that did not react with monocytes were 
directed against idiotypic determinants on B cell lymphoma (21). 
Monocytes were resuspended after culture in PBS containing 0.25% 
HSA and 0.02% azide. Before the immunofluorescence test the 
monocytes were incubated with 10% human serum in PBS for 30 
min. This was done to avoid nonspecific binding of the mouse IgG2 a 
Fc region of the test mAb to the FC7RI, which is known to nonspe- 
cifically bind mouse IgG2a antibodies. Blocking of the FcyRI with 
human IgG does not interfere with the binding of the anti-FC7 RI 
mAb 32.2, because this mAb detects a nonfunctional domain. Im­
munofluorescence tests were carried out by incubating the mono­
cytes with mAb (in PBS/HSA/azide) for 30 min at 0°C. Subsequently, 
the monocytes were washed and incubated with FITC-labeled goat 
F(ab)2 anti-mouse IgG antibody (Tago Inc., Burlingame, CA) for 30 
min at 0°C. Fluorescence intensity was analyzed with a FACScan 
(Becton Dickinson, Mountain View, CA). Data are expressed as mean 
fluorescence intensity (arbitrary units) as measured on 4 decades 
logarithmic amplifyer.
ADCC. Cultured monocytes were tested for their capacity to lyse 
antibody-coated Rh+ E. E were labeled with anti-D test serum (Cen­
tral Laboratory of the Netherlands Red Cross Blood Transfusion 
Service (CLB), Amsterdam, The Netherlands) or mouse mAb CLB- 
ery/1 directed against glycophorin A on human E (a kind gift of M. 
Bos, Department of Immunohaematology, CLB, Amsterdam, The 
Netherlands). Human Rh+ E (50 fil packed cells) were labeled with 
100 ¿iCi Na251Cr04 and 100 /il anti-D test serum or 100 //} antiglyco- 
phorin A mAb (1/100) for 1 h at 37°C, after which the cells were 
washed twice with PBS. Cultured monocytes and labeled E were 
resuspended in DMEM supplemented with 10% FCS and 2.5 X 105 
labeled target cells were mixed with various numbers of effector 
monocytes in 200 ¿d medium in U-shaped 96-wells plates. To allow 
sufficient cell-cell contact the plates were centrifuged for 5 min and 
incubated during 20 h at 37°C and 5% C 02. After this incubation 
period 100 jul supernatant were collected from each well and counted 
in a gamma counter. All tests were carried out in triplicate.
The percentage specific 51 Cr release was calculated according to
the formula:
BtCr release of sample -  51Cr release in medium ^------------------- -------- ------------ -------------------------- x 100%
51Cr release in 1% Triton X-100 -  51Cr release in medium 
The student's ¿-test was used for statistical analysis of the data.
RESULTS
IL-4 d ecrea ses  FcyRI, FcyRII, and FcyRIII surface  
express ion  on h u m a n  monocytes. Freshly isolated 
m onocytes express a t  least two FC7R, namely FC7 RI and  
FcyRII, and a  th ird , FC7RIII, is induced after culture. 
Because IL-4-induced alterations in the expression of 
su rface m em brane Ag on hum an monocytes can in gen ­
eral be detected a fte r  culture in 100 U/ml of IL-4 for 1 to 
3 days (6), we cu ltu red  monocytes for 40 h in the presence 
or absence of 100 U /m l of IL-4. Figure 1 shows th a t  IL-4 
w as capable of reducing the m em brane expression of 
FC7RI, FcyRII, and  FC7 RIII after 40 h  of culture. In con­
tra s t  IL-4 en h an ced  the expression of HLA-DR/DP Ag 
and  induced expression  of FceRIIb (Fig. 1), indicating th a t  
IL-4 does not cause  a general nonspecific reduction of Ag 
expression on th e  cell surface. Figure 2A show s a tim e 
course experim ent in  which it is dem onstrated th a t  100  
U /m l of IL-4 block FC7 R expression starting  from day 2 
of culture and  th is  persisted during the whole culture 
period (7 days). F igure 2B  shows a dose-response curve 
of the  effect of IL-4 on the FC7R m em brane expression. 
The resu lts  ind icate  th a t  maximal decrease in  expression 
of all th ree  FC7 R is found at a concentration of 100 U/m l 
of IL-4. This inh ib ition  of FC7R on monocytes is specific 
for IL-4 because  anti-IL-4 antibodies completely abrogate 
th e  IL-4-induced decrease in FC7R m em brane expression
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Figure 2. A, Time course of the effect of IL-4 on the expression of 
FC7R. B, Concentration dependent down regulation of FC7R on human 
monocytes. The cells were cultured for 0, 1,2,  3, 5, and 7 days (A) or 40 
h (B) with 100 U/ml of IL-4 (A) or increasing concentrations of IL-4 (B). 
After culture the fluorescence analysis was carried out as described in 
the legends of Figure 1. Data are expressed as absolute mean fluorescence 
intensity (fluorescence Index) calculated according to the formula:
FI — mPl test sample — mFI negative control (isotype matched)
mFI negative control (isotype matched)
(Fig. 3), w hereas control rabb it an tise ru m  w as ineffec­
tive. It seem s unlikely th a t th e  effects of IL-4 are  due to 
contam inating  cells because th e  m onocyte p repara tions 
w ere always more th an  95% p u re  an d  also because ad­
dition of 1 0 %> contam inating lym phocytes to pu re  mono­
cyte fractions did no t affect th e  inh ib ito ry  effect of IL-4 
on FcyR expression (results n o t show n).
These results dem onstrate th a t  IL-4 induces a  reduc­
tion of the m em brane expression  of FcyRI, FcyRII, and  
F cyRIII on hum an  monocytes b u t en h an ces  th e  expres­
sion of FceRIIb.
IL-4 decreases IFN-y-induced up~regulatton o f Fey RI 
surface expression  on h u m a n  m onocytes .  IFN-y 
strongly enhances the expression  of FcyRI on h u m an  
monocytes (3, 4). We have previously dem onstra ted  th a t  
IFN-y can  act as a n  an tagonist of IL-4 on B cells (22-24) 
and  on monocytes (see footnote 4). Therefore, w e studied 
th e  effect of IL-4 on the IFN-Y-induced m em b ran e  expres­
sion of FC7RI. Im m unofluorescence stud ies show  th a t  
IL-4 inhibits the IFN-7 -induced up-regulation  of expres­
sion on monocytes (Fig. 4). M axim al inh ib ition  (55%) of 
FcyRI m em brane expression can  be achieved using IL-4 
concentrations of more th a n  200 U /m l. A sim ilar type of 
inhibition can be observed w hen  m onocytes are in cu ­
bated for 24 h with 100  U /m l of IFN-y before th e  addition 
of IL-4. In addition, anti-IL-4 an tibod ies  block the IL-4- 
induced inhibition showing th e  specifity  of th is  inhibition 
(results not shown). Taken together, th ese  d a ta  dem on­
s tra te  th a t IL-4 partially in h ib its  th e  up-regulation  of 
m em brane expression of FcyRI in  th e  p resence of IFN-y-
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Figure 3. Addition of anti-IL-4 antiserum to human monocyte cultured 
in the presence of 100 U/ml of IL-4 completely restores FC7RI, FC7RII, 
and FC7RIII expression. The cells were cultured for 40 h in medium alone
(••*)■ in 100 U/ml of IL-4 (-----) or 100 U/ml of IL-4 with anti-IL-4
antiserum (1/500 dilution) (---- ). Control rabbit antiserum was ineffective
(results not shown]. Fluorescence analysis was carried out as described 
in the legends of Figure 1. One representative experiment of three is 
shown.
IL-4 reduces ADCC activity of h u m a n  monocytes. To 
determ ine w h e th er reduced FcyR expression reflected 
reduced functional Fc-induced activity of the  cells, we 
investigated th e  eff ect of IL-4 on the capacity  to lyse anti- 
D opsonized h u m an  Rh+ E. The observed cytotoxicity 
tow ard anti-D  opsonized E apparently  reflects the activity 
of FcyRI (11). Figure 5 shows th a t th e  ADCC activity of 
monocytes cu ltured  in the presence of IL-4 is reduced. A 
sim ilar dose of 100 U/ml of IL-4 th a t  causes maximal 
reduction in  m em brane expression of FcyR (Fig. 2) also 
causes m axim al reduction of ADCC. To exclude the pos­
sibility th a t Fc-mediated phagocytosis in terferes with 
ADCC in  th e  20-h  chromium release assay , we carried 
out short term  4-h  chromium release assays in which Fc- 
m ediated phagocytosis does not play a significant role 
(25). We obtained similar results (not shown) compared
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Figure 4, IL-4 inhibits IFN-7-enhanced FcyRI expression of mono­
cytes. The cells were cultured for 40 h with and without 100 U/ml of IFN- 
7 and increasing concentrations of IL-4. Fluorescence analysis was car­
ried out as described In the legends of Figure 1. One representative 
experiment of three is shown.
E/T ratio
Figure 5. IL-4 inhibits ADCC activity of monocytes against anti-D- 
coated human E. The monocytes were cultured for 40 h In increasing 
concentrations of IL-4. ADCC tests were performed as described in Ma­
terials and Methods, Data are expressed as percentage 5lCr release. SD 
did not exceed 10%. One representative experiment of six is shown.
preferen tia lly  b ind  to  F cyR II (8). T he  re su lts  in Figure 6 
show  th a t  ADCC m edia ted  via m u rin e  IgGl can  be signif­
ican tly  reduced w hen  th e  effector m onocytes are cu ltured  
in  th e  p resence of IL-4. To d e m o n s tra te  th a t  th e  reduced 
ADCC activity  of m onocy tes cu ltu red  in  th e  presence of 
IL-4 is specific, we cu ltu red  m onocytes w ith  and  w ithout 
IL-4 in  th e  p resence  of anti-IL -4  a n tise ru m . T he resu lts  
in  Figure 7 show  th a t  anti-IL-4 a n ti  se ru m  completely 
neu tra lized  th e  inh ib ito ry  effec ts  of IL-4, w h ereas  control 
ra b b it  an tise ru m  w as ineffective.
T ak en  together th e  re su lts  d em o n stra te  th a t  IL-4-re- 
duced  m em brane  exp ression  of F cyR  corre la tes well w ith  
th e  reduced capacity  to lyse an tibody-coated  targets.
IL-4 d e c re a se s  IF N -y-induced  ADCC a c tiv i ty  o f  h u ­
m a n  m o n o cy te s .  IFN-y not only s tim u la te s  the expres­
sion  of th e  FcyRI on  m onocyte m e m b ra n e s  b u t also e n ­
h an ces  ADCC activ ity  m ed ia ted  v ia  th is  recep tor (26). 
In asm u ch  as IL-4 red u ces  th e  IFN-Y-induced m em brane
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with the 20-h assay, indicating th a t  IL-4 p rim arily  re ­
duces the ADCC activity, although we c a n n o t exclude th e  
possibility th a t IL-4 h as  an  effect on Fc-m ediated  p h ago­
cytosis. To investigate the  influence of IL-4 on th e  F cyRII- 
mediated cytotoxicity, we m easured th e  effect of IL-4 on 
the ADCC of h u m an  E opsonized w ith  a  m ouse IgGl 
antibody-against glycophorin A. Mouse IgGl an tibod ies
% anti-IL-4 anti serum
Figure 7, Addition of anti-IL-4 antiserum to human monocyte cultures 
In the presence of 100 U/ml of IL-4 completely restores ADCC activity 
against anti-D-coated human E. The cells were cultured for 40 h with or 
without 100 U/ml of IL-4 and increasing concentrations of anti-IL-4 
antiserum. ADCC tests were performed.as described in Materials and 
Methods. Control rabbit antiserum was ineffective (results not shown). 
Data are expressed as percentage 5,Cr release. E/T ratio was 0.4. SD did 
not exceed 10%. One representative experiment of three is shown.
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expression of FcyRI on m onocytes, we tested  the  ADCC 
activity of m onocytes cultured w ith  IFN-7 in  th e  presence 
of increasing  concentrations of IL-4. T he resu lts  pre­
sented  in  Figure 8 show a dose-dependent decrease in 
ADCC activity of IFN-7 -stim ulated m onocytes in  the  p re s ­
ence of IL-4. These data  indicate th a t  n o t only th e  m em ­
b ran e  expression of FcyRI is reduced on  IFN-7 -stim ulated  
m onocytes upon culture w ith  iL-4, bu t also th e ir  capacity 
to lyse antibody-coated targets.
DISCUSSION
The expression of FC7R on h u m a n  m onocytes is readily 
regulated by endogeneous stim uli of w hich  IFN-7 is the  
m ost im portant. We p resen t d a ta  show ing  th a t  IL-4 
causes a  decrease in  expression of FC7 R by h u m a n  m ono­
cytes, w hich directly correlates w ith  Fc7 R-m ediated 
function  as  m easured by ADCC activity. T he finding th a t 
IL-4 is a  lym phokine th a t is capable of affecting FcyR 
expression is in accordance w ith  th e  observation th a t  
IL-4 induces a  loss of FC7 RII ligand b ind ing  Eictivity on B 
lymphocytes (27) and  th a t IL-4 in h ib its  th e  enhanced  
expression of FC7RII by LPS-stim ulated B cells (28). This 
indicates th a t  IL-4 is not only involved in  th e  regulation 
of FC7R-m ediated function of m onocytes b u t also of B 
lymphocytes.
Because in previous studies tim e course experim ents 
indicate th a t changes in su rface  m em b ran e  expression 
of h u m an  m onocytes could be detected a fte r  2  days of 
culture (6), th e  experim ents show n h e re  w ere carried  out 
w ith m onocytes cu ltured  for 40  h  (Fig. 2A). A fter 2 days 
of culture not only IL-4-induced MHC class II Ag expres­
sion, C D llb /C D 1 8  and  C D llc /C D 1 8  expression  (6), bu t 
also FceRIIb expression can be observed on h u m an  m ono­
cytes (8 ). A sim ilar tim e course of FcyRI* IL-2R and  MHC 
class II Ag expression w as found a fte r  IFN-y tre a tm e n t of 
m onocytes (29). In addition a f te r  2 days of cu ltu re  h u m a n  
m onocytes express not only FC7 RI a n d  FC7 RII bu t also 
FC7 RIII. The individual contribution  of th e  FC7 R to ligand 
binding and  functional activity are  n o t yet clearly iden­
tified although it has been suggested  th a t  the  ADCC 
against E opsonized w ith  h u m a n  anti-D  antibodies is
E/T ratio
Figure S. IL-4 inhibits IFN-7-enhanced ADCC activity of human 
monocytes against anti-D coated human E. The cells were cultured for 
40 h in medium alone (■), with 100 U/ml of IFN-7 (•), 100 U/ml of IL-4 
(A) or with 100 U/ml of 1FN-y + 10 U (□), + 100 U (O). or + 200 U/ml (A) 
of IL-4. ADCC tests were performed as described in Materials and Meth­
ods, Data are expressed as percentage 51 Cr release. SD did not exceed 
10%. One representative experiment of three is shown.
m ediated via FcyRI because blockade of FC7RI abrogated 
th is  ADCC (11). F urtherm ore, enhanced  FC7 RI expression 
observed in the  p resence of IFN-7 (Fig. 4) resu lts  in strong 
ADCC activity ag a in s t anti-D  opsonized E (Fig. 8). Block­
ade of FC7 RII abrogated  the  ADCC activity against E 
opsonized w ith  IgG m urine  antibodies (30). We exploited 
th e  preferen tia l b ind ing  of hum an  IgG to FcyRI and 
mlgGl to FcyRH to elucidate the  relative contribution of 
th e  FcyRI and  FcyRH in  FcYR-mediated cytotoxic activity. 
The resu lts  dem onstra te  th a t the  IL-4-induced reduction 
in  m em brane expression  of FcyRI and  FcyRH correlates 
well w ith  a reduced capacity to lyse h u m a n  polyclonal 
IgG anti-D or mlgG 1 antiglycophorin A opsonized human
E. Especially th e  IFN-Y-induced FcyRI expression and 
cytotoxic function  is down regulated by IL-4 (Figs. 4 and 
8). FcyRIH is p redom inantly  expressed by cultured mono­
cytes and  although it is capable of b inding ligand (10 , 
1 1 ), it h a s  recently  been reported th a t  th e  newly ex­
pressed FcyRIII on m onocytes is not involved in the in­
duction of ADCC of h u m an  E opsonized w ith  either anti- 
D or antig lycophorin  A (11), Although th e  reduced FC7R 
expression correlates well w ith a  reduced ADCC activity 
we canno t exclude th e  possibility th a t  th ere  are other 
monocyte Ag a n d /o r  functions im portan t for mediating 
ADCC activity dow n-regulated in the presence of IL-4. An 
indication th a t IL-4 not only inhibits ADCC by decreasing 
FcyR expression, b u t  also affects the  0 2” metabolism is 
show n by Lehn et al. (31) who describe th a t  IL-4 inhibits 
the  IFN-Y-induced H20 2 production of h u m an  cultured 
monocytes.
In addition to IFN-y and IL-4, o ther factors have been 
show n to regulate FcyR expression of one or more FC7R. 
LPS has  been described to inhibit IFN-Y-induced FcyR 
expression on h u m an  monocytes and  th is  effect is 
though t to be m ediated by IL-1 and  TNF produced by 
monocytes a f te r  exposure to LPS (32). It is very unlikely 
th a t IL-1 and  TNF are  responsible for the  inhibitory effect 
of IL-4 on FcyR expression on h u m an  monocytes shown 
in th is  study, because IL-4 strongly blocks secretion of 
IL-1 and  TNF by these  cells (7) (see footnote 3). However, 
we canno t exclude th e  possibility th a t  o ther IL-4 induced 
factor(s) are  responsible for th e  dow n-regulation of FC7R.
A num ber of stud ies have show n th a t  IFN-y has antag­
onistic effects on IL-4-induced expression of FcfRII and 
class II MHC Ag on norm al and  m alignan t B cells (22- 
24). IFN-y also blocks IL-4-induced FcfRIIb expression on 
hum an  m onocytes (see footnote 4). We show  that IL-4 
has  antagonizing effects on IFN-Y-induced FcyR expres­
sion and  FcYR-mediated cytotoxic function . These results 
suggest th a t  IFN-y is a  lymphokine specifically involved 
in FcyR regulation and IgG responses by stimulating 
FcyR expression an d  function and reducing FccR expres­
sion, w hereas IL-4 is a  lymphokine specifically involved 
in FceR regulation an d  IgE responses because it induces 
FcdR expression and  inhibits FC7R expression and func­
tion. F ine-regulation of the individual production of 
IFN-y and IL-4 m ay therefore control the  FcR surface 
expression and  functional activity of the FcR, thus reg­
ulating the  direction of the  FcR-m ediated immune re­
sponse.
A ckn o w led g m en ts . We acknowledge Drs. C. J . M. Me- 
lief and  T. W. J . Huizinga for critically reading the man-
IL-4 REDUCES FcTR EXPRESSION AND ADCC ACTIVITY OF MONOCYTES 3051
uscript, M. Dessing for FACScan analysis , and  M. A. van  
Halem for secretaria l help.
REFERENCES
1. Adams D. O., and T. A. Hamilton. 1984, The cell biology of macro­
phage activation. Annu. Rev. Immunol. 2:238.
2. Steeg, P. S., R. N. Moore, H, M. Johnson, and J. J. Oppenheim.
1982. Regulation of murine macrophage la antigen expression by a 
lymphokine with immune interferon activity. J. Exp. Med. 
156:1780.
3. Perussia, B., E. T. Dayton, R. Lazarus, V. Fanning, and G. Trin- 
chieri. 1983. Immune Interferon induces the receptor for monomeric 
IgGl on human monocytic and myeloid cells. J. Exp. Med. 158:1092.
4. Guyre, P. M., P. M. Morganelli, and R. Miller. 1983. Recombinant 
immune interferon Increases immunoglobulin G Fc receptors on 
human mononuclear phagocytes. J. Clin. Invest 72:393.
5. Grabstein, K. H., D. L. Urdal, R. J. Tushinski, D. Y. Mochizuki, V. 
L. Price, M. A. Cantrell, S. Gillis, and P. J. Conlon. 1986. Induction 
of macrophage tumorlcidal activity by granulocyte-macrophage col­
ony-stimulating factor. Science 232:506.
6. Te Velde, A. A., J. P. G. Klomp, B. A. Yard, J. E, de Vries, and C. 
G. Figdor. 1988. Modulation of phenotypic and functional properties 
of human peripheral blood monocytes by IL-4. J. Immunol. 
140:1548.
7. Essner, R., K. Rhoades, W. H. McBride, D . L . Morton, and J. S. 
Economou. 1989. IL-4 down-regulates IL-1 and TNF gene expression 
in human monocytes. J. Immunol. 142:3861.
8. Vercelli, D., H. H. Jabara, B. W. Lee, N. Woodland, R. S. Geha, and
D. Y. M. Leung. 1988. Human recombinant Interleukin 4 induces 
FceR2/CD23 on normal human monocytes. J. Exp. Med. 167:1406,
9. Anderson, C. L., and R. J. Looney. 1986. Human leukocyte IgG Fc 
receptors. Immunol. Today 7:264.
10. Clarkson, S. B., and P. A. Dry. 1988. CD16 developmentally regu­
lated IgG Fc receptors on cultured human monocytes, J, Exp. Med. 
167:408.
11. Klaassen, R. J. L., W. H. Ouwehand, T. W. J. Huizinga, C, P. 
Engelfriet, and A. E. G. Kr. von dem Borne. 1990, The Fc-receptor 
III of cultured human monocytes; similarity with FC7RIII on natural- 
killer cells and role in the extracellular lysis of sensitized erythro­
cytes. J, Immunol, 144:599.
12. Morgan, E. L., and W. O. Weigle. 1987. Biological activities residing 
in the Fc region of immunoglobulin. Adv. Immunol. 40:61.
13. Figdor, C. G., W. S. Bont, I. Touw, D. Roos, E. E. Roosnek, and J.
E. de Vries. 1982. Isolation of functionally different human mono­
cytes by counterflow centrifugation elutratlon. Blood 60:46.
14. Figdor, C. G., W. L. van Es, J. M. M. Leemans, and W. S. Bont. 
1984. A centrifugal elutratlon system of separation small numbers 
of cells. J. Immunol. Methods 68:73.
15. Yssel, H., J. E. de Vries, M. Koken, W. van Blitterswijk, and H, 
Spits. 1984. Serum-free medium for generation and propagation of 
functional human cytotoxic and helper T cell clones. J. Immunol, 
Methods 72:219.
16. Yokota, T., T. Otzuka, T. Mosmann, J. Bancherau, T. De France,
D. Blanchard, J, E. De Vries, F. Lee, and K. I. Arai. 1986. Isolation 
and characterization of a human interleukin cDNA clone, homolo­
gous to mouse B-cell stimulatory factor 1, that expresses B-cell- and 
T-cell-stimulating activities. Proc. Natl. Acad. Sci. USA 83:5894.
17. Chretien, I., A. van Kimmenade, M. K. Pearce, J. Bancherau, and 
J, S. Abrams. 1989. Development of polyclonal and monoclonal 
antibodies for immuno assay and neutralization of human interleu­
kin-4, J. Immunol Methods 11 7:67.
18. Miedema, F., P. A. T. Tetteroo, W. G, Hesselink, G. Werner, H, 
Spits, and C. J. M. Melief. 1984. Both Fc receptors and lymphocyte- 
function-associated antigen 1 on human T lymphocytes are required 
for antibody-dependent cellular cytotoxicity (killer cell activity), Eur. 
J. Immunol. 14:518.
19. Quaranta, V., L. E. Walker, M. A. Pellegrino, and S. Ferrone. 1980. 
Purification of immunologically functional subsets of human Ia-like 
antigens on a monoclonal antibody (Q5/13) Immunoadsorbent. J. 
Immunol. 125:1421.
20. Bonnefoy, J. Y., J. P. Aubry, C. Peronne, J, Wijdenes, and J. 
Bancherau, 1987. Production and characterization of a monoclonal 
antibody specific for the human low affinity receptor for IgE: CD23 
is a low affinity receptor for IgE. J. Immunol 138:2970.
21. Rankin, E., and A. Hekman. 1984, Mouse monoclonal antibodies 
against the idiotype of human B cell non-Hodgkin lymphomas: pro­
duction, characterization and use to monitor the progress of disease. 
Eur. J. Immunol. 14:1119.
22. Rabin, E. M., J. J. Mond, J. Ohara, and W. E. Paul. 1986. Interferon- 
7 inhibits the action of B cell stimulatory factor (BSF)-l on resting B 
cells. J. Immunol. 137:15 73.
23. De France, T., J. P. Aubry, F. Rousset, B. van der Vliet, J, Y. 
Bonnefoy, N, Arai, Y.Takebe, T. Yokota, F. Lee, K. Arai, J. de 
Vries, and J. Bancherau. 1987. Human recombinant interleukin 4 
induces Fee receptors. (CD23) on normal human B lymphocytes. J. 
Exp. Med. 165:1459,
24. Rousset, F., R. de Waal Malefijt, B. Slierendrecht, J. P. Aubry, J. 
Bonnefoy, T. De France, J, Bancherau, and J. E. de Vries. 1988. 
Regulation of Fc receptor for IgE (CD23) and class II MHC antigen 
expression on Burkitt’s lymphoma cell lines by human IL-4 and IFN-
7 . J , imrmmoi. 140:2625.
25. Beelen, R. H. J., and W. S. Walker. 1985. Exocytosis and macro- 
phage-mediated antibody-dependent cellular cytotoxicity; a caution­
ary note. Immunology 51:535,
26. Trinchieri, G., and B. Perussia. 1985, Immune interferon: a pleio- 
tropic lymphokine with multiple effects. Immunol. Today 6:131,
27. Laszlo, G,, and H. B. Dickler. 1988. IL-4 induces loss of B lymphocyte 
FC7RI ligand binding capacity. J. Immunol. 141:3416.
28. Snapper, C. M., J. J. Hooley, U. Atasoy, F. D. Finkelman, and W.
E. Paul. 1989. Differential regulation of murine B cell FC7RII expres­
sion by CD4* T helper subsets. J. Immunol. 143:2133.
29. Jayaran, Y., A, M. Buckle, and N. Hogg. 1989. The Fc receptor, 
FcRl and other activation molecules on human mononuclear phag­
ocytes after treatment with interferon-gamma. Clin. Exp. Immunol. 
75:414,
30. Boot, J. H. A., M. E. J. Geerts, and L. A. Aarden. 1989. Functional 
polymorphisms of Fc receptors in human monocyte-mediated cyto­
toxicity towards erythrocytes induced by murine isotype-switch var­
iants. J. Immunol 142:1217.
31. Lehn, M., W. Y. Weiser, S. Engelhorn, S. Gillis, and H. G. Remold. 
1989. IL-4 inhibits H20 2 production and antileishmanial capacity of 
human cultured monocytes mediated by IFN-7 . J. Immunol. 
143:3020.
32. Arend, W. P., J. T. Ammons, and B, L. Kotzin. 1987. Lipopolysac- 
charide and interleukin 1 inhibit lnterferon-7-induced Fc receptor 
expression on human monocytes, J. Immunol, 139:1873,
